Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.

Antimicrobial agents and chemotherapy - 1 Nov 2005

Juan Carlos, Maciá María D, Gutiérrez Olivia, Vidal Carmen, Pérez José L, Oliver Antonio

Abstract excerpt

The molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in natural strains of Pseudomonas aeruginosa were investigated in a collection of 10 isogenic, ceftazidime-susceptible and -resistant pairs of isolates, each sequentially recovered from a different intensive care unit patient treated with beta-lactams. All 10 ceftazidime-resistant mutants hyper-produced AmpC (beta-lactamase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Proteins
Share to beta-Lactam Resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to beta-Lactamases

Share to Ceftazidime

Share to Microbial Sensitivity Tests

Share to Operon

Share to Plasmids

Share to Pseudomonas aeruginosa

Source

Open in PubMed Open full text

Identifiers

PMID: 16251318
DOI: 10.1128/AAC.49.11.4733-4738.2005
PMCID: PMC1280133

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.PMID 16251318Read ↗

Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression.Semantic proximity Read ↗

Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance.Semantic proximity Read ↗

Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.Semantic proximity Read ↗

Complex Regulation Pathways of AmpC-Mediated β-Lactam Resistance in Enterobacter cloacae Complex.Semantic proximity Read ↗

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated PathwaysSemantic proximity Read ↗

Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin.Semantic proximity Read ↗

Chromosomal system for studying AmpC-mediated beta-lactam resistance mutation in Escherichia coli.Semantic proximity Read ↗

The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.Semantic proximity Read ↗

Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.Semantic proximity Read ↗

Genetic basis of induction and overproduction of chromosomal class I beta-lactamase in nonfastidious gram-negative bacilli.Semantic proximity Read ↗

Progression of ampC amplification during de novo amoxicillin resistance development in E. coli.Semantic proximity Read ↗

Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different beta-lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic region.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.